In this study, we evaluated whether YAP‐1, OTX‐2, and Nestin, which may be important for NB, could be new descriptive markers for the determination of stage and treatment strategies, especially according to risk groups and N‐MYC expression status. This evidence concerns the gene OTX2 and neuroblastoma.